Aquinox Pharmaceuticals CEO Jonathan Drachman receives $3.8M in 2019
Aquinox Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: March 24, 2020
Aquinox Pharmaceuticals reported fiscal year 2019 executive compensation information on March 24, 2020.
In 2019, three executives at Aquinox Pharmaceuticals received on average a compensation package of $2.3M, a 12% decrease compared to previous year.
Average pay of disclosed executives at Aquinox Pharmaceuticals
Jonathan Drachman, Chief Executive Officer, received $3.8M in total. 90% of Drachman's compensation, or $3.4M, was in option awards. Drachman also received $241K in non-equity incentive plan and $137K in salary.
David J. Main, Chief Executive Officer, received a compensation package of $2M, which decreased by 54% compared to previous year. 81% of the compensation package, or $1.6M, was in other compensation.
Kamran Alam, Chief Financial Officer, earned $1.2M in 2019, a 32% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on March 24, 2020.